Synthetic Gene Therapy Partnerships
Our synthetic gene therapy approach has been designed as a structurally modular approach, which can be used to treat a wide range of human rare and usually orphan monogenic diseases or complex multifactorial disorders that are muche more freuqnrt.
New synthetic gene therapies can be developed for the treatment of liver diseases, as well as secreted-protein related deficiency disorders, with virtually optimization of the current system. In addition, disorders of affecting most other organs can be also targeted with some optimization of our system.
Pharmaceutical and biotech partners who share with us our desire to revolutionize medicine and want to collaborate to make a real change are welcome.